#1 Clinical Trials Search in Europe

Milnacipran Hydrochloride

Milnacipran hydrochloride, also known by the brand name Savella, is a medication being studied in clinical trials for its potential to treat various chronic pain conditions. This article summarizes key findings from recent trials examining milnacipran’s effects on conditions like fibromyalgia, back pain, irritable bowel syndrome, and more. We’ll explore how this drug works, its dosing, and what researchers have learned about its ability to relieve pain and improve quality of life for patients.

Table of Contents

What is Milnacipran?

Milnacipran hydrochloride, also known by the brand name Savella, is a medication that belongs to a class of drugs called serotonin and norepinephrine reuptake inhibitors (SNRIs)[1]. It is primarily used to treat various chronic pain conditions and has been studied for its effects on mood and fatigue[2].

Conditions Treated with Milnacipran

Milnacipran has been investigated for its effectiveness in treating several conditions, including:

  • Fibromyalgia: A chronic condition characterized by widespread muscle pain and tenderness, often accompanied by fatigue, sleep, memory, and mood issues[3].
  • Chronic shoulder pain: Persistent pain in the shoulder area that lasts for an extended period[1].
  • Chronic back pain: Long-lasting pain in the back region[2].
  • Knee osteoarthritis: A degenerative joint disease affecting the knee, causing pain and reduced mobility[4].
  • Irritable Bowel Syndrome (IBS): A common digestive disorder characterized by abdominal pain and changes in bowel habits[5].
  • Systemic Lupus Erythematosus (SLE): An autoimmune disease that can affect various parts of the body, often causing fatigue and pain[6].

How Milnacipran Works

Milnacipran works by increasing the levels of two important neurotransmitters in the brain: serotonin and norepinephrine. These chemicals play a crucial role in regulating mood, pain perception, and other bodily functions. By enhancing their activity, milnacipran may help reduce pain and improve overall well-being in patients with chronic pain conditions[3].

Dosage and Administration

The dosage of milnacipran can vary depending on the condition being treated and the individual patient’s response. Generally, the medication is taken orally, usually twice daily. Here are some common dosing regimens observed in clinical trials:

  • For fibromyalgia: Doses ranging from 100 mg to 200 mg per day, divided into two doses[7].
  • For chronic pain conditions: Starting doses of 50 mg twice daily, with potential increases up to 100 mg twice daily if needed and tolerated[1][5].

It’s important to note that your doctor will determine the appropriate dosage for your specific condition and may adjust it based on your response and any side effects you experience.

Clinical Studies and Effectiveness

Several clinical studies have been conducted to evaluate the effectiveness of milnacipran in treating various conditions:

  • Fibromyalgia: Studies have shown that milnacipran can significantly reduce pain and improve overall symptoms in patients with fibromyalgia[3].
  • Chronic pain: Research has indicated potential benefits in reducing pain intensity and improving quality of life in patients with chronic shoulder pain and back pain[1][2].
  • Knee osteoarthritis: A study explored the use of milnacipran for pain relief and improvement in physical function in patients with knee osteoarthritis[4].
  • Irritable Bowel Syndrome: Research has investigated the potential of milnacipran in reducing abdominal pain and improving quality of life in IBS patients[5].
  • Systemic Lupus Erythematosus: A study examined the effects of milnacipran on fatigue and quality of life in lupus patients with widespread pain or fibromyalgia[6].

These studies have used various measures to assess the effectiveness of milnacipran, including pain scales, quality of life questionnaires, and patient-reported outcomes.

Potential Side Effects

Like all medications, milnacipran can cause side effects. Some of the potential side effects observed in clinical studies include:

  • Nausea
  • Headache
  • Constipation
  • Dizziness
  • Insomnia
  • Increased heart rate or blood pressure[7]

It’s important to discuss any side effects you experience with your healthcare provider. They can help determine if the benefits of the medication outweigh the risks for your specific situation.

Condition Studied Dosage Range Key Outcomes Measured Notable Findings
Fibromyalgia 100-200 mg/day Pain, patient global status, physical function Composite responder analysis used to assess effectiveness
Chronic Back Pain 50-100 mg twice daily Pain intensity, mood, sleep, quality of life Investigated if pain sensitivity affected treatment response
Knee Osteoarthritis Up to 200 mg/day Pain, physical function, fatigue, sleep quality Used electronic diaries and activity monitors to track outcomes
Irritable Bowel Syndrome 50-100 mg twice daily Abdominal pain, quality of life, adequate relief Compared different dosing regimens over 12 weeks
Chronic Shoulder Pain 100-200 mg/day Pain reduction, global impression of change, shoulder function 16-week study including 4-week follow-up after treatment

FAQ

  • What is milnacipran hydrochloride? Milnacipran hydrochloride is a medication that belongs to a class of drugs called serotonin and norepinephrine reuptake inhibitors (SNRIs). It works by increasing levels of serotonin and norepinephrine in the brain, which can help regulate pain signals and mood.
  • What conditions is milnacipran being studied for? Clinical trials are investigating milnacipran for several chronic pain conditions, including fibromyalgia, chronic back pain, irritable bowel syndrome (IBS), knee osteoarthritis, and chronic shoulder pain.
  • How is milnacipran typically given in these trials? In most trials, milnacipran is given as oral tablets, usually twice daily. Doses often start low and gradually increase, with common maintenance doses ranging from 50 mg to 200 mg per day, divided into two doses.
  • What are some common outcomes measured in these trials? Researchers typically measure changes in pain intensity, often using scales like the Visual Analog Scale (VAS). They also look at improvements in quality of life, physical function, fatigue, sleep, and mood. Some trials use condition-specific questionnaires to assess symptoms.
  • Are there any side effects of milnacipran reported in these trials? While specific side effects aren't detailed in the trial summaries provided, SNRIs like milnacipran can sometimes cause nausea, dry mouth, constipation, decreased appetite, and increased sweating. It's important to discuss potential side effects with a healthcare provider.

Ongoing Clinical Trials on Milnacipran Hydrochloride

  • Study on the Effect of Ketamine and Esketamine in Patients with Major Depressive Disorder After First-Line Treatment Failure

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Germany Greece Italy Spain

Glossary

  • Milnacipran hydrochloride: A medication that belongs to the class of drugs called serotonin and norepinephrine reuptake inhibitors (SNRIs). It works by increasing levels of certain chemicals in the brain to help regulate pain signals and mood.
  • Fibromyalgia: A chronic condition characterized by widespread muscle pain and tenderness, often accompanied by fatigue, sleep, memory and mood issues.
  • Irritable Bowel Syndrome (IBS): A common disorder that affects the large intestine, causing symptoms like abdominal pain, cramping, bloating, and changes in bowel habits.
  • Osteoarthritis: A type of joint disease that results from breakdown of joint cartilage and underlying bone, often causing pain and stiffness.
  • Visual Analog Scale (VAS): A measurement tool used to help patients rate the intensity of certain sensations and feelings, such as pain. It is usually a straight line with one end meaning no pain and the other end meaning the worst pain imaginable.
  • Quality of Life (QOL): A broad concept that encompasses a person's physical health, psychological state, level of independence, social relationships, and relationship to their environment.
  • Placebo: An inactive substance or treatment that looks the same as, and is given in the same way as, an active drug or treatment being tested. The effects of the active treatment are compared to the effects of the placebo.
  • Double-blind study: A type of clinical trial where neither the participants nor the researchers know who is receiving the active treatment and who is receiving the placebo until after the trial is completed.

References

  1. https://clinicaltrials.gov/study/NCT01289236
  2. https://clinicaltrials.gov/study/NCT01221740
  3. https://clinicaltrials.gov/study/NCT00098124
  4. https://clinicaltrials.gov/study/NCT01510457
  5. https://clinicaltrials.gov/study/NCT01471379
  6. https://clinicaltrials.gov/study/NCT01359826
  7. https://clinicaltrials.gov/study/NCT00618956